1
|
Seiter D, Chen R, Ludwig KD, Zhu A, Shah D, Wieben O, Johnson KM. Velocity-selective arterial spin labeling perfusion measurements in 2nd trimester human placenta with varying BMI. Placenta 2024; 150:72-79. [PMID: 38615536 PMCID: PMC11065564 DOI: 10.1016/j.placenta.2024.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 03/19/2024] [Accepted: 03/22/2024] [Indexed: 04/16/2024]
Abstract
INTRODUCTION Proper placental development is crucial to fetal health but is challenging to functionally assess non-invasively and is thus poorly characterized in populations. Body mass index (BMI) has been linked with adverse outcomes, but the causative mechanism is uncertain. Velocity-selective arterial spin labeling (VS-ASL) MRI provides a method to non-invasively measure placental perfusion with robustness to confounding transit time delays. In this study, we report on the measurement of perfusion in the human placenta in early pregnancy using velocity-selective arterial spin labeling (VS-ASL) MRI, comparing non-obese and obese participants. METHODS Participants (N = 97) undergoing routine prenatal care were recruited and imaged with structural and VS-ASL perfusion MRI at 15 and 21 weeks gestation. Resulting perfusion images were analyzed with respect to obesity based on BMI, gestational age, and the presence of adverse outcomes. RESULTS At 15 weeks gestation BMI was not associated with placental perfusion or perfusion heterogeneity. However, at 21 weeks gestation BMI was associated with higher placental perfusion (p < 0.01) and a decrease in perfusion heterogeneity (p < 0.05). In alignment with past studies, perfusion values were also higher at 21 weeks compared to 15 weeks gestation. In a small cohort of participants with adverse outcomes, at 21 weeks lower perfusion was observed compared to participants with uncomplicated pregnancies. DISCUSSION These results suggest low placental perfusion in the early second trimester may not be the culpable factor driving associations of obesity with adverse outcomes.
Collapse
Affiliation(s)
- Daniel Seiter
- Medical Physics, University of Wisconsin-Madison, Madison, WI, United States
| | - Ruiming Chen
- Medical Physics, University of Wisconsin-Madison, Madison, WI, United States
| | - Kai D Ludwig
- Medical Physics, University of Wisconsin-Madison, Madison, WI, United States
| | - Ante Zhu
- Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States; Radiology, University of Wisconsin-Madison, Madison, WI, United States
| | - Dinesh Shah
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI, United States
| | - Oliver Wieben
- Medical Physics, University of Wisconsin-Madison, Madison, WI, United States; Radiology, University of Wisconsin-Madison, Madison, WI, United States
| | - Kevin M Johnson
- Medical Physics, University of Wisconsin-Madison, Madison, WI, United States; Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States; Radiology, University of Wisconsin-Madison, Madison, WI, United States.
| |
Collapse
|
2
|
Chen R, Seiter D, Keding LT, Vazquez J, Antony KM, Simmons HA, Basu P, Mejia AF, Johnson KM, Stanic AK, Liu RY, Shah DM, Golos TG, Wieben O. Cotyledon-Specific Flow Evaluation of Rhesus Macaque Placental Injury Using Ferumoxytol Dynamic Contrast-Enhanced MRI. J Magn Reson Imaging 2024. [PMID: 38375996 DOI: 10.1002/jmri.29291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 01/29/2024] [Accepted: 01/29/2024] [Indexed: 02/21/2024] Open
Abstract
BACKGROUND Recently, dynamic contrast-enhanced (DCE) MRI with ferumoxytol as contrast agent has recently been introduced for the noninvasive assessment of placental structure and function throughout. However, it has not been demonstrated under pathological conditions. PURPOSE To measure cotyledon-specific rhesus macaque maternal placental blood flow using ferumoxytol DCE MRI in a novel animal model for local placental injury. STUDY TYPE Prospective animal model. SUBJECTS Placental injections of Tisseel (three with 0.5 mL and two with 1.5 mL), monocyte chemoattractant protein 1 (three with 100 μg), and three with saline as controls were performed in a total of 11 rhesus macaque pregnancies at approximate gestational day (GD 101). DCE MRI scans were performed prior (GD 100) and after (GD 115 and GD 145) the injection (term = GD 165). FIELD STRENGTH/SEQUENCE 3 T, T1-weighted spoiled gradient echo sequence (product sequence, DISCO). ASSESSMENT Source images were inspected for motion artefacts from the mother or fetus. Placenta segmentation and DCE processing were performed for the dynamic image series to measure cotyledon specific volume, flow, and normalized flow. Overall placental histopathology was conducted for controls, Tisseel, and MCP-1 animals and regions of tissue infarctions and necrosis were documented. Visual inspections for potential necrotic tissue were conducted for the two Tisseelx3 animals. STATISTICAL TESTS Wilcoxon rank sum test, significance level P < 0.05. RESULTS No motion artefacts were observed. For the group treated with 1.5 mL of Tisseel, significantly lower cotyledon volume, flow, and normalized flow per cotyledon were observed for the third gestational time point of imaging (day ~145), with mean normalized flow of 0.53 minute-1 . Preliminary histopathological analysis shows areas of tissue necrosis from a selected cotyledon in one Tisseel-treated (single dose) animal and both Tisseelx3 (triple dose) animals. DATA CONCLUSION This study demonstrates the feasibility of cotyledon-specific functional analysis at multiple gestational time points and injury detection in a placental rhesus macaque model through ferumoxytol-enhanced DCE MRI. LEVEL OF EVIDENCE NA TECHNICAL EFFICACY: Stage 2.
Collapse
Affiliation(s)
- Ruiming Chen
- Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Daniel Seiter
- Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Logan T Keding
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Jessica Vazquez
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Kathleen M Antony
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Heather A Simmons
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Puja Basu
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Andres F Mejia
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Kevin M Johnson
- Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Aleksandar K Stanic
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Ruo-Yu Liu
- Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Dinesh M Shah
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Thaddeus G Golos
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Comparative Biosciences, University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - Oliver Wieben
- Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA
- Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA
| |
Collapse
|
3
|
Raza F, Kozitza C, Lechuga C, Seiter D, Corrado P, Merchant M, Dharmavaram N, Korcarz C, Eldridge M, Francois C, Wieben O, Chesler N. Multimodality Deep Phenotyping Methods to Assess Mechanisms of Poor Right Ventricular-Pulmonary Artery Coupling. Function (Oxf) 2022; 3:zqac022. [PMID: 35774590 PMCID: PMC9228647 DOI: 10.1093/function/zqac022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/18/2022] [Revised: 04/01/2022] [Accepted: 04/20/2022] [Indexed: 01/07/2023]
Abstract
Deep phenotyping of pulmonary hypertension (PH) with multimodal diagnostic exercise interventions can lead to early focused therapeutic interventions. Herein, we report methods to simultaneously assess pulmonary impedance, differential biventricular myocardial strain, and right ventricular:pulmonary arterial (RV:PA) uncoupling during exercise, which we pilot in subjects with suspected PH. As proof-of-concept, we show that four subjects with different diagnoses [pulmonary arterial hypertension (PAH); chronic thromboembolic disease (CTEPH); PH due to heart failure with preserved ejection fraction (PH-HFpEF); and noncardiac dyspnea (NCD)] have distinct patterns of response to exercise. RV:PA coupling assessment with exercise was highest-to-lowest in this order: PAH > CTEPH > PH-HFpEF > NCD. Input impedance (Z0) with exercise was highest in precapillary PH (PAH, CTEPH), followed by PH-HFpEF and NCD. Characteristic impedance (ZC) tended to decline with exercise, except for the PH-HFpEF subject (initial Zc increase at moderate workload with subsequent decrease at higher workload with augmentation in cardiac output). Differential myocardial strain was normal in PAH, CTEPH, and NCD subjects and lower in the PH-HFpEF subject in the interventricular septum. The combination of these metrics allowed novel insights into mechanisms of RV:PA uncoupling. For example, while the PH-HFpEF subject had hemodynamics comparable to the NCD subject at rest, with exercise coupling dropped precipitously, which can be attributed (by decreased myocardial strain of interventricular septum) to poor support from the left ventricle (LV). We conclude that this deep phenotyping approach may distinguish afterload sensitive vs. LV-dependent mechanisms of RV:PA uncoupling in PH, which may lead to novel therapeutically relevant insights.
Collapse
Affiliation(s)
| | - Callyn Kozitza
- Biomedical Engineering, University of Wisconsin-Madison, Wisconsin, USA
| | - Chris Lechuga
- Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center and Department of Biomedical Engineering, University of California, Irvine, USA
| | - Daniel Seiter
- Medical Physics, University of Wisconsin-Madison, Wisconsin, USA
| | - Philip Corrado
- Medical Physics, University of Wisconsin-Madison, Wisconsin, USA
| | - Mohammed Merchant
- Department of Medicine, Cardiovascular Division, University of Wisconsin-Madison, Wisconsin, USA
| | - Naga Dharmavaram
- Department of Medicine, Cardiovascular Division, University of Wisconsin-Madison, Wisconsin, USA
| | - Claudia Korcarz
- Department of Medicine, Cardiovascular Division, University of Wisconsin-Madison, Wisconsin, USA
| | - Marlowe Eldridge
- Department of Pediatrics, University of Wisconsin-Madison, Wisconsin, USA
| | | | - Oliver Wieben
- Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center and Department of Biomedical Engineering, University of California, Irvine, USA
| | - Naomi Chesler
- Medical Physics, University of Wisconsin-Madison, Wisconsin, USA
| |
Collapse
|
4
|
Sarrut D, Bała M, Bardiès M, Bert J, Chauvin M, Chatzipapas K, Dupont M, Etxebeste A, M Fanchon L, Jan S, Kayal G, S Kirov A, Kowalski P, Krzemien W, Labour J, Lenz M, Loudos G, Mehadji B, Ménard L, Morel C, Papadimitroulas P, Rafecas M, Salvadori J, Seiter D, Stockhoff M, Testa E, Trigila C, Pietrzyk U, Vandenberghe S, Verdier MA, Visvikis D, Ziemons K, Zvolský M, Roncali E. Advanced Monte Carlo simulations of emission tomography imaging systems with GATE. Phys Med Biol 2021; 66:10.1088/1361-6560/abf276. [PMID: 33770774 PMCID: PMC10549966 DOI: 10.1088/1361-6560/abf276] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Accepted: 03/26/2021] [Indexed: 12/13/2022]
Abstract
Built on top of the Geant4 toolkit, GATE is collaboratively developed for more than 15 years to design Monte Carlo simulations of nuclear-based imaging systems. It is, in particular, used by researchers and industrials to design, optimize, understand and create innovative emission tomography systems. In this paper, we reviewed the recent developments that have been proposed to simulate modern detectors and provide a comprehensive report on imaging systems that have been simulated and evaluated in GATE. Additionally, some methodological developments that are not specific for imaging but that can improve detector modeling and provide computation time gains, such as Variance Reduction Techniques and Artificial Intelligence integration, are described and discussed.
Collapse
Affiliation(s)
- David Sarrut
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1294, INSA-Lyon, Université Lyon 1, Lyon, France
| | | | - Manuel Bardiès
- Cancer Research Institute of Montpellier, U1194 INSERM/ICM/Montpellier University, 208 Av des Apothicaires, F-34298 Montpellier cedex 5, France
| | - Julien Bert
- LaTIM, INSERM UMR 1101, IBRBS, Faculty of Medicine, Univ Brest, 22 avenue Camille Desmoulins, F-29238, Brest, France
| | - Maxime Chauvin
- CRCT, UMR 1037, INSERM, Université Toulouse III Paul Sabatier, Toulouse, France
| | | | | | - Ane Etxebeste
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1294, INSA-Lyon, Université Lyon 1, Lyon, France
| | - Louise M Fanchon
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, United States of America
| | - Sébastien Jan
- Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Service Hospitalier Frédéric Joliot, F-91401, Orsay, France
| | - Gunjan Kayal
- CRCT, UMR 1037, INSERM, Université Toulouse III Paul Sabatier, Toulouse, France
- SCK CEN, Belgian Nuclear Research Centre, Boeretang 200, Mol 2400, Belgium
| | - Assen S Kirov
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, United States of America
| | - Paweł Kowalski
- High Energy Physics Division, National Centre for Nuclear Research, Otwock-Świerk, Poland
| | - Wojciech Krzemien
- High Energy Physics Division, National Centre for Nuclear Research, Otwock-Świerk, Poland
| | - Joey Labour
- Université de Lyon, CREATIS, CNRS UMR5220, Inserm U1294, INSA-Lyon, Université Lyon 1, Lyon, France
| | - Mirjam Lenz
- FH Aachen University of Applied Sciences, Forschungszentrum Jülich, Jülich, Germany
- Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany
| | - George Loudos
- Bioemission Technology Solutions (BIOEMTECH), Alexandras Av. 116, Athens, Greece
| | | | - Laurent Ménard
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, F-91405 Orsay, France
- Université de Paris, IJCLab, F-91405 Orsay France
| | | | | | - Magdalena Rafecas
- Institute of Medical Engineering, University of Lübeck, Lübeck, Germany
| | - Julien Salvadori
- Department of Nuclear Medicine and Nancyclotep molecular imaging platform, CHRU-Nancy, Université de Lorraine, F-54000, Nancy, France
| | - Daniel Seiter
- Department of Medical Physics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, 53705, United States of America
| | - Mariele Stockhoff
- Medical Image and Signal Processing (MEDISIP), Ghent University, Ghent, Belgium
| | - Etienne Testa
- Univ. Lyon, Univ. Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, F-69622, Villeurbanne, France
| | - Carlotta Trigila
- Department of Biomedical Engineering, University of California, Davis, CA 95616 United States of America
| | - Uwe Pietrzyk
- Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany
| | | | - Marc-Antoine Verdier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, F-91405 Orsay, France
- Université de Paris, IJCLab, F-91405 Orsay France
| | - Dimitris Visvikis
- LaTIM, INSERM UMR 1101, IBRBS, Faculty of Medicine, Univ Brest, 22 avenue Camille Desmoulins, F-29238, Brest, France
| | - Karl Ziemons
- FH Aachen University of Applied Sciences, Forschungszentrum Jülich, Jülich, Germany
| | - Milan Zvolský
- Institute of Medical Engineering, University of Lübeck, Lübeck, Germany
| | - Emilie Roncali
- Department of Biomedical Engineering, University of California, Davis, CA 95616 United States of America
| |
Collapse
|
5
|
Kirov AS, Fanchon LM, Seiter D, Czmielewski C, Russell J, Dogan S, Carlin S, Pinker-Domenig K, Yorke E, Schmidtlein CR, Boyko V, Fujisawa S, Manova-Todorova K, Zanzonico P, Dauer L, Deasy JO, Humm JL, Solomon S. Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injection. Med Phys 2018; 45:2179-2185. [PMID: 29480927 DOI: 10.1002/mp.12836] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 02/14/2018] [Accepted: 02/15/2018] [Indexed: 11/08/2022] Open
Abstract
PURPOSE Genomic profiling of biopsied tissue is the basis for precision cancer therapy. However, biopsied materials may not contain sufficient amounts of tumor deoxyribonucleonic acid needed for the analysis. We propose a method to determine the adequacy of specimens for performing genomic profiling by quantifying their metabolic activity. METHODS We estimated the average density of tumor cells in biopsy specimens needed to successfully perform genomic analysis following the Memorial Sloan Kettering Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) protocol from the minimum amount of deoxyribonucleonic acid needed and the volume of tissue typically used for analysis. The average 18 F-FDG uptake per cell was assessed by incubating HT-29 adenocarcinoma tumor cells in 18 F-FDG containing solution and then measuring their activity with a scintillation well counter. Consequently, we evaluated the response of two devices around the minimum expected activities which would indicate genomic profiling adequacy of biopsy specimens obtained under 18 F-FDG PET/CT guidance. Surrogate samples obtained using 18G core needle biopsies of gels containing either 18 F-FDG-loaded cells in the expected concentrations or the corresponding activity were measured using autoradiography and a scintillation well counter. Autoradiography was performed using a CCD-based device with real-time image display as well as with digital autoradiography imaging plates following a 30-min off-line protocol for specimen activity determination against previously established calibration. RESULTS Cell incubation experiments and estimates obtained from quantitative autoradiography of biopsy specimens (QABS) indicate that specimens acquired under 18 F-FDG PET/CT guidance that contained the minimum amount of cells needed for genomic profiling would have an average activity concentration in the range of about 3 to about 9 kBq/mL. When exposed to specimens with similar activity concentration, both a CCD-based autoradiography device and a scintillation well counter produced signals with sufficient signal-to-background ratio for specimen genomic adequacy identification in less than 10 min, which is short enough to allow procedure guidance. CONCLUSION Scintillation well counter measurements and CCD-based autoradiography have adequate sensitivity to detect the tumor burden needed for genomic profiling during 18 F-FDG PET/CT-guided 18G core needle biopsies of liver adenocarcinoma metastases.
Collapse
Affiliation(s)
- Assen S Kirov
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Louise M Fanchon
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | | | - Christian Czmielewski
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - James Russell
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Snjezana Dogan
- Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Sean Carlin
- Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Katja Pinker-Domenig
- Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Ellen Yorke
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - C Ross Schmidtlein
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Vitaly Boyko
- Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Sho Fujisawa
- Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Katia Manova-Todorova
- Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Pat Zanzonico
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Lawrence Dauer
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Joseph O Deasy
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - John L Humm
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| | - Stephen Solomon
- Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA
| |
Collapse
|